Elsevier

Nutrition Research

Volume 83, November 2020, Pages 30-48
Nutrition Research

Review Article
Phytochemicals affect T helper 17 and T regulatory cells and gut integrity: implications on the gut-bone axis

https://doi.org/10.1016/j.nutres.2020.08.006Get rights and content

Abstract

The pathology of osteoporosis is multifactorial, but a growing body of evidence supports an important role of the gut-bone axis, especially in bone loss associated with menopause, rheumatoid arthritis, and periodontal disease. Aberrant T cell responses favoring an increase in the ratio of T helper 17 cells to T regulatory cells play a critical role in the underlying etiology of this bone loss. Many of the dietary phytochemicals known to have osteoprotective activity such as flavonoids, organosulfur compounds, phenolic acids, as well as the oligosaccharides also improve gut barrier function and affect T cell differentiation and activation within gut-associated lymphoid tissues and at distal sites. Here, we examine the potential of these phytochemicals to act as prebiotics and immunomodulating agents, in part targeting the gut to mediate their effects on bone.

Introduction

Worldwide, 8.9 million osteoporotic fractures occur each year, which ultimately afflict 1 in 3 women and 1 in 5 men over the age of 50 years [[1], [2], [3], [4]]. Although genetic influences on peak bone mass are one of the major determinants of overall fracture risk, nutrition plays a critical role in optimizing peak bone mass and the metabolic processes that determine bone quality across the lifespan. For example, dietary protein and calcium, primarily from animal products, combined with the endogenous production of vitamin D, are required to achieve optimal peak bone mass during growth and early adulthood, and they can influence the rate at which age-related bone loss occurs in older adults. Moreover, micronutrients such as copper, zinc, and vitamins C and K are required for collagen cross-linking and mineralization of the protein matrix (i.e., osteoid) during the formation phase of bone metabolism [5,6]. Still other nutrients and components of the diet, especially those from plant-based foods, act to mitigate oxidative stress and inflammatory processes within the microenvironment of bone that can dysregulate bone metabolism.

Plant-based foods are well‐known for serving as an excellent source of nondigestible carbohydrates and phytochemicals, both of which have osteoprotective properties. Some nondigestible carbohydrates (e.g., fructooligosaccharides [FOS] and inulin) increase bone mineral density (BMD) in animal models and human studies, a response that has historically been attributed to enhanced intestinal calcium and magnesium absorption elicited by an increase in microbiota-derived short chain fatty acids (SCFAs) causing a downward shift in luminal pH [[7], [8], [9]]. Furthermore, several different classes of phytochemicals with osteoprotective activity, including flavonoids, organosulfur compounds, and phenolic acids, are potent scavengers of free radicals and suppress pro‐inflammatory cytokine production by immune cells, especially dendritic and T helper (Th) 17 cell populations. Elevated proinflammatory cytokines such as interleukin (IL)-1, IL-6, IL-17, and tumor necrosis factor (TNF)-α can promote osteoclast activity while simultaneously suppressing the bone forming capacity of osteoblasts [10]. More recently, there has been a growing appreciation for phytochemicals’ ability to activate immunosuppressive cell populations such as the T regulatory (Treg) and Th2 cells with anti-inflammatory activity [11]. In contrast to Th17 cells that secrete IL-17, Tregs secrete cytokines (e.g., IL-10 and -4) that inhibit osteoclast formation and promote osteoblast differentiation by mediating Wnt family member 10b (Wnt10b) signaling [12,13]. It is these functions of phytochemicals on T lymphocytes—especially Th17 and Treg cells—that are of particular interest relative to bone health given their central role in the bone loss associated with menopause, rheumatoid arthritis (RA), and periodontitis [[14], [15], [16]].

The scientific literature supporting the benefits of the phytochemicals from plant-based foods on bone is substantial, but many questions remain as to the specific target(s) of their activity and how these effects are conveyed. In vitro studies have shown that a number of different phytochemicals directly alter osteoblast and osteoclast activity through bone morphogenetic protein (BMP), mitogen-activated protein kinase (MAPK), and receptor activator for nuclear factor κ-B (RANK) and its ligand (RANKL) signaling [[17], [18], [19], [20]]. However, phytochemicals with phenolic ring structures have low aqueous solubility and are relatively poorly absorbed in the gastrointestinal (GI) tract. These phytochemicals’ bioavailability depends in large part on the extent to which they are metabolized by microorganisms residing within the lumen, which leads to a favorable change in the composition of the microbiota (i.e., inhibiting pathogenic bacteria and stimulating the growth of commensal bacteria). Additionally, the production of secondary metabolites from many phytochemicals (e.g., SCFAs) can contribute to health benefits for the host locally within the gut and at distal sites such as the bone [21]. Consequently, in vitro studies focused on the direct effects of the parent compounds on bone cells only offer a partial explanation of the mechanisms through which phytochemicals influence bone metabolism [22]. Many phytochemicals and their secondary metabolites can also directly alter the activation intestinal epithelial and dendritic cells, which produce cytokines and chemokines that regulate CD4+ T cell differentiation and activation. Thus, it stands to reason that the ability of some of these compounds to regulate the differentiation and activation of CD4+ T cells, and T cells’ ability to traffic from the gut to distal lymphatic tissues, including the bone marrow, would provide novel mechanisms by which phytochemicals benefit bone [23]. In this review, we will provide an overview of how the concept of the gut-bone axis has evolved over time, including recent findings highlighting the role of the microbiota and gut mucosal immunity on bone metabolism, and then examine how some of the major classes of phytochemicals that are known to improve bone health affect key targets linking the gut and bone.

Section snippets

Gut-bone axis as a potential target for phytochemicals

The concept that pathologies involving the GI system have negative implications on bone health is not new. A case report published in the late 1940s [24] provided an account of a female patient diagnosed with steatorrhea and osteomalacia; subsequent radiological findings revealed the patient suffered from whole body osteoporosis. In the early 1950s, bone changes characterized as osteomalacia were also described in patients with celiac disease [25]. Initially, these gut-bone relationships were

Flavonoids

Flavonoids are the largest class of phytochemicals, comprised of more than 6000 compounds divided into 6 subgroups (i.e., flavonols, flavones, flavanones, isoflavones, anthocyanins, and flavanols). Found in the leaves of plants, fruits, vegetables, and legumes, some of the best dietary sources include teas, onions and scallions, citrus fruits, soy and cocoa products, and berries and fruits that are red, blue, and purple in color. These compounds are among the earliest and most extensively

Organosulfur compounds

Organosulfur compounds, including allicin, sulforaphane, and γ-glutamyl cysteine, are found most abundantly in vegetables belonging to the allium (e.g., garlic and onion) and brassica or cruciferous (e.g., cabbage, cauliflower, and broccoli) families. Much of the research on the health benefits of these compounds has been in the areas of cancer and cardiovascular disease prevention because of their effects on cell cycle arrest, apoptosis, and the inhibition of cholesterol synthesis [[130], [131]

Phenolic acids

Phenolic acids are naturally occurring plant metabolites containing 2 distinguishing carbon frameworks: the hydroxycinnamic and hydroxybenzoic structures [159]. Hydroxycinnamic acids in plants include p-coumaric, caffeic, chlorogenic, ferulic, sinapic, and quinic acids, whereas hydroxybenzoic acids include p-hydroxybenzoic, protocatechuic, vanillic, ellagic, and gallic acids. These compounds are abundant in the skin and seeds of fruits, making the content in dried fruits (e.g., blueberries,

Oligosaccharides

Another widely studied class of plant-based compounds that exert positive effects on bone is nondigestible oligosaccharides. Oligosaccharides from soluble corn fiber, FOS, and inulin have been reported to improve bone and calcium homeostasis [[184], [185], [186]]. FOS and inulin can be consumed as supplements or through dietary sources such as onion, chicory root, banana, garlic, and asparagus. However, it is worth noting that several of the fruits rich in flavonoids and phenolic acids (e.g.,

Other phytochemicals

From a review of the literature, it apparent that there are other classes of dietary phytochemicals reported to have favorable effects on one or more aspects of the gut-bone axis. These include the carotenoids, omega-3 fatty acids, and lignans. Because of a lack of evidence or inconsistencies in the literature, there is a less compelling case for these phytochemicals to act via immune T cell–modulating effects on the gut–bone axis at this time. However, it is important that these phytochemicals

Future research

Initially fueled by discoveries from studies using germ-free mice and probiotics, the concept that the gut microbiome and gut-associated lymphoid tissue could serve as novel targets for the prevention of bone loss has emerged. These discoveries have revealed previously unappreciated links between microbiota-derived metabolites, gut barrier function, mucosal immunity, and bone metabolism. As a result, a great deal of interest in the gut-bone axis has been generated, which has significant

Acknowledgments

This work was funded in part by the Oklahoma Agricultural Experiment Station (OKL03105). The authors have no conflicts of interest to disclose.

References (266)

  • B. Smith

    Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation

    Bone

    (2006)
  • P. Dey

    Green tea extract prevents obesity in male mice by alleviating gut dysbiosis in association with improved intestinal barrier function that limits endotoxin translocation and adipose inflammation

    J Nutr Biochem

    (2019)
  • S. Aggarwal

    Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

    J Biol Chem

    (2003)
  • T.F. Teixeira

    Potential mechanisms for the emerging link between obesity and increased intestinal permeability

    Nutr Res

    (2012)
  • K. Taku

    Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials

    Bone

    (2010)
  • W.W. Wong

    Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial

    Am J Clin Nutr

    (2009)
  • D. Alekel et al.

    Soy isoflavones for reducing bone loss (SIRBL) study: three-year randomized controlled trial to determine efficacy and safety of soy isoflavones to reduce bone loss in postmenopausal women

    Am J Clin Nutr

    (2010)
  • B.H. Arjmandi

    Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content

    Am J Clin Nutr

    (1998)
  • O. Johnell et al.

    An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

    Osteoporos Int

    (2006)
  • L.J. Melton

    Bone density and fracture risk in men

    J Bone Miner Res

    (1998)
  • J.L. Melton

    Perspectives: how many women have osteoporosis now?

    J Bone Miner Res

    (1995)
  • J. Kanis

    Long-term risk of osteoporotic fracture in Malmö

    Osteoporos Int

    (2000)
  • H. Tsuchiya et al.

    Vitamin C and copper interactions in guinea-pigs and a study of collagen cross-links

    Br J Nutr

    (1997)
  • Price, P.A., Vitamin K–dependent formation of bone Gla protein (osteocalcin) and its function, in Vitamins & hormones....
  • L.L. Legette

    Prebiotics enhance magnesium absorption and inulin-based fibers exert chronic effects on calcium utilization in a postmenopausal rodent model

    J Food Sci

    (2012)
  • C.M. Whisner et al.

    Prebiotics, bone and mineral metabolism

    Calcif Tissue Int

    (2018)
  • D.J. Morrison et al.

    Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism

    Gut Microbes

    (2016)
  • Weitzmann, M.N., Bone and the immune system, in Bone toxicology. 2017, Springer. p....
  • C. Luo

    Estrogen enhances the functions of CD4+ CD25+ Foxp3+ regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro

    Cell Mol Immunol

    (2011)
  • Tyagi, A.M., et al., The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated...
  • A. Cope et al.

    The central role of T cells in rheumatoid arthritis

    Clin Exp Rheumatol

    (2007)
  • W.C. Cheng et al.

    The presence, function and regulation of IL-17 and Th17 cells in periodontitis

    J Clin Periodontol

    (2014)
  • Graef, J.L., et al., Osteoclast differentiation is downregulated by select polyphenolic fractions from dried plum via...
  • J.R. Chen

    Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/β-catenin canonical Wnt signaling

    J Bone Miner Res

    (2010)
  • X. Wu

    Caffeic acid 3, 4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways

    J Bone Miner Res

    (2012)
  • G.R. Gibson

    Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics

    Nat Rev Gastroenterol Hepatol

    (2017)
  • S. Gao et al.

    Bioavailability challenges associated with development of anti-cancer phenolics

    Mini-Rev Med Chem

    (2010)
  • D. Short

    Osteomalacia associated with steatorrhoea: report of a case

    Glasgow Medical Journal

    (1948)
  • H.A. SALVESEN et al.

    Osteomalacia in sprue

    J Intern Med

    (1953)
  • J. Jahnsen

    Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease

    Scand J Gastroenterol

    (2002)
  • C. Hwang et al.

    Micronutrient deficiencies in inflammatory bowel disease: from A to zinc

    Inflamm Bowel Dis

    (2012)
  • J. Compston

    Osteoporosis in patients with inflammatory bowel disease

    Gut

    (1987)
  • F.C. Edwards et al.

    Course and prognosis of ulcerative colitis: part III complications

    Gut

    (1964)
  • K. Sjögren

    The gut microbiota regulates bone mass in mice

    J Bone Miner Res

    (2012)
  • M. Schwarzer

    Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition

    Science

    (2016)
  • C.M. Novince

    Commensal gut microbiota immunomodulatory actions in bone marrow and liver have catabolic effects on skeletal homeostasis in health

    Sci Rep

    (2017)
  • J.-Y. Li

    Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics

    J Clin Invest

    (2016)
  • R.A. Britton

    Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model

    J Cell Physiol

    (2014)
  • C. Ohlsson

    Probiotics protect mice from ovariectomy-induced cortical bone loss

    PLoS One

    (2014)
  • M.R. Messora

    Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis

    J Periodontol

    (2013)
  • Cited by (8)

    View all citing articles on Scopus
    View full text